Takeda Pharmaceutical
Sabari Surendran, Pharm.D., RPh, currently serves as a Senior Principal Pharmacovigilance Scientist at Takeda, focusing on medical safety in gastrointestinal and inflammation areas since April 2023. Prior experience includes roles as Manager Safety Analysis Scientist and Pharmacovigilance Evaluation and Reporting Post-Doctoral Scientist Fellow at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2020 to April 2023. Sabari also completed various pharmacy externships and fellowships at organizations such as Johns Hopkins Bayview Medical Center, Johnson & Johnson, and AstraZeneca, gaining extensive experience in regulatory affairs, infectious disease medicine, and global patient safety. Education includes a Doctor of Pharmacy from Notre Dame of Maryland University and a Pre-Pharmacy Track from Wayne State University.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.